Sebastien Beauzile’s recently announced cure from sickle cell disease brings hope to thousands of mostly Black Americans who suffer from the rare disease, but the multi-million dollar cost of the gene-editing therapy raises question about access and affordability. “I’m not in pain anymore. I’ve been able to do a lot of new things,” 21-year-old Beauzile […]
